Insulet | Los Gastos De Explotación



Operating Expenses Cambio Fecha
Abbott USD 8.7B 363M 2025-03
Align Technology USD 848.16M 2.91M 2025-03
AtriCure USD 129.57M 9.23M 2025-03
Avanos Medical USD 157.2M 440.9M 2025-03
Baxter International USD 3.19B 644M 2024-12
Becton, Dickinson and Co. USD 4.73B 11M 2025-03
Boston Scientific USD 3.74B 144M 2025-03
Cardinal Health USD 54.15B 567M 2025-03
Cooper Companies USD 782.7M 37.3M 2025-01
Dexcom USD 902.3M 22.3M 2025-03
Edwards Lifesciences USD 1.02B 55.3M 2025-03
Eli Lilly USD 7.32B 1.06B 2025-03
Globus Medical USD 501.12M 95.9M 2025-03
ICU Medical USD 592.11M 11.22M 2024-12
Insulet USD 519.7M 31.5M 2025-03
Integra LifeSciences USD 398.61M 8.81M 2025-03
J&J USD 8.26B 10.37B 2025-03
Masimo USD 294M 665.8M 2025-03
Medtronic USD 7.49B 845M 2025-04
Merit Medical Systems USD 314.32M 4.28M 2025-03
Roche Holding CHF 11.43B 1.48B 2024-12
Solventum Corp 1.92B 20M 2025-03
Stryker USD 5.03B 826M 2025-03
Tandem Diabetes Care USD 355.3M 72.07M 2025-03
Teleflex USD 570.34M 335.45M 2025-03
West Pharmaceutical Services USD 591M 1.8M 2025-03
Zimmer Biomet Holdings USD 1.63B 89.5M 2024-12



Insulet Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.